reference/22158770

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/22158770

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase II\|Journal Article\|Multicenter Study\|Research Support, Non-U.S. Gov't
endingPage	126
issn	2152-2650
issueIdentifier	2
pageRange	118-126
publicationName	Clinical Lymphoma Myeloma and Leukemia
startingPage	118
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_41db7eaa287675438660403756af36a2 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_9d1d1034efa511bb25e7033cdf6acfc7
bibliographicCitation	Teoh G, Chen Y, Kim K, Srivastava A, Pai VR, Yoon SS, Suh C, Kim YK. Lower dose dexamethasone/thalidomide and zoledronic acid every 3 weeks in previously untreated multiple myeloma. Clin Lymphoma Myeloma Leuk. 2012 Apr;12(2):118–26. doi: 10.1016/j.clml.2011.11.002. PMID: 22206804.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_891e95c0d9d822cab70af9a0d40e4df0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a727f6486e73ad52eb99a5c87fb2b626 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1e6f732b2b6f916e3edf74b852337f75 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-5878-8895 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1c5044b843d3efe19451133b1f186ddb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_eeedf35f1494577a66ae7c0156464e22 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0e51fed4814d597b35c05eda78ff6c4e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_44df1366fd132c4ef33ca05ed445a08a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d3a81a14d227139062c86d646eba5584
date	201204
identifier	https://pubmed.ncbi.nlm.nih.gov/22206804 https://doi.org/10.1016/j.clml.2011.11.002
isPartOf	https://portal.issn.org/resource/ISSN/2152-2650 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/37305
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Lower Dose Dexamethasone/Thalidomide and Zoledronic Acid Every 3 Weeks in Previously Untreated Multiple Myeloma
discusses	http://id.nlm.nih.gov/mesh/M0006519 http://id.nlm.nih.gov/mesh/M0021267 http://id.nlm.nih.gov/mesh/M0011048 http://id.nlm.nih.gov/mesh/M0234600 http://id.nlm.nih.gov/mesh/M0006099
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D009101Q000188 http://id.nlm.nih.gov/mesh/D000971Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D003907Q000008 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D004164Q000008 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D000077211 http://id.nlm.nih.gov/mesh/D007093Q000008 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D009101Q000401 http://id.nlm.nih.gov/mesh/D013792Q000008 http://id.nlm.nih.gov/mesh/D008954 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D000971Q000009
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8530 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8235 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5426 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5743 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8167 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68740 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8735 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8854 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10308

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129356432 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129728658

Total number of triples: 62.